Update of the Mechanism and Characteristics of Tuberculosis in Chronic Kidney Disease : Review Article

Overview

Journal Wien Klin Wochenschr

Publisher Springer

Specialty General Medicine

Date 2022 Mar 7

PMID 35254535

Authors

Xuehan Zhang

Pingshan Chen

Gaosi Xu

Affiliations

Soon will be listed here.

Abstract

The risk of tuberculosis (TB) is significantly increased in patients with chronic kidney disease (CKD), which is closely related to hyperparathyroidism, malnutrition and oxidative stress as well as immune deficiency in patients with end-stage renal disease (ESRD). Vitamin D deficiency and gender bias are independent risk factors. In the TB screening and diagnosis test of CKD, interferon-gamma release assays (IGRA), including T‑SPOT.TB test (T-SPOT) and QuantiFERON-TB Gold In-Tube (QFT-GIT) have been available. Many studies have found that they are more sensitive and specific than tuberculin skin test (TST). At present, IGRA has been used to study various types of immunocompromised patients. For CKD patients with TB, the choice and dosage of anti-TB drugs need to be reconsidered. Weekly treatment with rifapentin (RFT) and isoniazid (INH) for 3 months is an effective treatment for latent tuberculosis infection (LTBI) in hemodialysis (HD) patients. Therefore, in this review we discuss CKD and TB, its pathogenesis, clinical features, diagnosis and treatment advancements.

Citing Articles

Non-communicable comorbidities in pulmonary tuberculosis and healthcare utilization: a cross-sectional study of 2021 Indonesian national health insurance data.

Prasiska D, Chapagain D, Osei K, Rajaguru V, Kang S, Kim T Arch Public Health. 2024; 82(1):127.

PMID: 39160626 PMC: 11331679. DOI: 10.1186/s13690-024-01352-y.

Diagnosis of Latent Tuberculosis Infection in Hemodialysis Patients: TST versus T-SPOT.TB.

Binay U, Kara A, Karakecili F, Barkay O Diagnostics (Basel). 2023; 13(14).

PMID: 37510113 PMC: 10378133. DOI: 10.3390/diagnostics13142369.

References

Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B . Chronic kidney disease: global dimension and perspectives. Lancet. 2013; 382(9888):260-72. DOI: 10.1016/S0140-6736(13)60687-X. View

Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P . Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021; 113 Suppl 1:S7-S12. PMC: 8433257. DOI: 10.1016/j.ijid.2021.02.107. View

Romanowski K, Clark E, Levin A, Cook V, Johnston J . Tuberculosis and chronic kidney disease: an emerging global syndemic. Kidney Int. 2016; 90(1):34-40. DOI: 10.1016/j.kint.2016.01.034. View

Moran E, Baharani J, Dedicoat M, Robinson E, Smith G, Bhomra P . Risk factors associated with the development of active tuberculosis among patients with advanced chronic kidney disease. J Infect. 2018; 77(4):291-295. DOI: 10.1016/j.jinf.2018.06.003. View

Hussein M, Mooij J, Roujouleh H . Tuberculosis and chronic renal disease. Semin Dial. 2003; 16(1):38-44. DOI: 10.1046/j.1525-139x.2003.03010.x. View

Getahun H, Matteelli A, Abubakar I, Abdel Aziz M, Baddeley A, Barreira D . Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J. 2015; 46(6):1563-76. PMC: 4664608. DOI: 10.1183/13993003.01245-2015. View

Lonnroth K, Migliori G, Abubakar I, DAmbrosio L, de Vries G, Diel R . Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J. 2015; 45(4):928-52. PMC: 4391660. DOI: 10.1183/09031936.00214014. View

Cahuayme-Zuniga L, Brust K . Mycobacterial Infections in Patients With Chronic Kidney Disease and Kidney Transplantation. Adv Chronic Kidney Dis. 2019; 26(1):35-40. DOI: 10.1053/j.ackd.2018.09.004. View

Hussein M, Mooij J . Tuberculosis and chronic renal disease. Saudi J Kidney Dis Transpl. 2008; 13(3):320-30. View

10.

Popova J, Yadrihinskaya V, Krylova M, Sleptsova S, Borisova N . Comparison of clinical and laboratory parameters in patients with end-stage renal failure in the outcome of chronic glomerulonephritis and patients with end-stage renal failure in the outcome of other diseases. Wiad Lek. 2017; 69(6):739-741. View

11.

Sathe K, Mehta K . Coexistence of atypical hemolytic uremic syndrome with membranoproliferative glomerulonephritis and antineutrophil cytoplasmic antibodies-associated vasculitis. Saudi J Kidney Dis Transpl. 2016; 27(4):800-4. DOI: 10.4103/1319-2442.185267. View

12.

Aibana O, Huang C, Aboud S, Arnedo-Pena A, Becerra M, Bellido-Blasco J . Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis. PLoS Med. 2019; 16(9):e1002907. PMC: 6738590. DOI: 10.1371/journal.pmed.1002907. View

13.

Shu C, Wei Y, Yeh Y, Lin H, Chen C, Wang P . The impact on incident tuberculosis by kidney function impairment status: analysis of severity relationship. Respir Res. 2020; 21(1):51. PMC: 7017479. DOI: 10.1186/s12931-020-1294-5. View

14.

Malik G, Al-Mohaya S, Al-Harbi A, Kechrid M, Azhari O, Shetia S . Spectrum of tuberculosis in dialysis patients in saudi arabia. Saudi J Kidney Dis Transpl. 2008; 14(2):145-52. View

15.

Hauser A, Stinghen A, Kato S, Bucharles S, Aita C, Yuzawa Y . Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Int. 2008; 28 Suppl 3:S183-7. View

16.

Gibbons R, Martinez O, Garovoy M . Altered monocyte function in uremia. Clin Immunol Immunopathol. 1990; 56(1):66-80. DOI: 10.1016/0090-1229(90)90170-u. View

17.

DIntini V, Bordoni V, Fortunato A, Galloni E, Carta M, Galli F . Longitudinal study of apoptosis in chronic uremic patients. Semin Dial. 2003; 16(6):467-73. DOI: 10.1046/j.1525-139x.2003.16101.x. View

18.

Peraldi M, Berrou J, Metivier F, Toubert A . Natural killer cell dysfunction in uremia: the role of oxidative stress and the effects of dialysis. Blood Purif. 2013; 35 Suppl 2:14-9. DOI: 10.1159/000350839. View

19.

Xiang F, Zhu J, Cao X, Shen B, Zou J, Liu Z . Lymphocyte depletion and subset alteration correlate to renal function in chronic kidney disease patients. Ren Fail. 2015; 38(1):7-14. DOI: 10.3109/0886022X.2015.1106871. View

20.

Dounousi E, Papavasiliou E, Makedou A, Ioannou K, Katopodis K, Tselepis A . Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis. 2006; 48(5):752-60. DOI: 10.1053/j.ajkd.2006.08.015. View